Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Grayscale Ethereum Staking ETFGrayscale Ethereum Trust Reports $2.77B Gain in Ether Investments for 2024
Grayscale Ethereum Staking Mini ETFGrayscale Ethereum Mini Trust ETF Reports $32.8 Million Loss on Ether Investments
Grayscale Bitcoin Mini Trust ETFGrayscale Bitcoin Mini Trust ETF Reports $980M Gain and Operational Changes for 2024
Olema Pharmaceuticals, Inc.Olema Pharmaceuticals Reports $129.4 Million Net Loss for 2024, Increased R&D Expenses
Natera, Inc.Natera Reports 56.7% Revenue Growth to $1.7 Billion in 2024
MARAVAI LIFESCIENCES HOLDINGS, INC.Maravai LifeSciences Reports $259.6M Net Loss and 10.3% Revenue Decline for 2024
MASTEC INCMasTec Inc. Reports $199.4 Million Net Income and $12.3 Billion Revenue for Fiscal Year 2024
Grayscale Bitcoin Trust ETFGrayscale Bitcoin Trust ETF Reports $16.38 Million Gain for 2024, Sees 27% Decrease in Net Assets
VERACYTE, INC.Veracyte Reports $24.1 Million Net Income and 23% Revenue Growth for Fiscal Year 2024
Trevi Therapeutics, Inc.Trevi Therapeutics Reports $47.9 Million Net Loss for 2024, Increases R&D Spending
Cytek Biosciences, Inc.Cytek Biosciences Reports $200.5M Revenue and $6M Net Loss for Fiscal Year 2024
LENZ Therapeutics, Inc.LENZ Therapeutics Reports $49.77 Million Net Loss for 2024, Prepares for LNZ100 Launch
NB Bancorp, Inc.NB Bancorp Reports $42.1 Million Net Income for 2024, Driven by Loan Growth
Neostellar Capital Corp.SuRo Capital Reports $13.95 Million Net Investment Loss for Fiscal Year 2024
MANGOCEUTICALS, INC.Mangoceuticals Reports $615,873 Revenue and $8.7M Net Loss for 2024
ALUMIS INC.Alumis Inc. Reports $294.2 Million Net Loss for 2024, Announces Merger with ACELYRIN Inc.
SERA PROGNOSTICS, INC.Sera Prognostics Reports $32.9 Million Net Loss for Fiscal Year 2024
Biofrontera Inc.Biofrontera Inc. Reports $17.8 Million Net Loss and $37.3 Million Revenue for Fiscal Year 2024
MetaVia Inc.NeuroBo Pharmaceuticals Reports $27.6 Million Net Loss for Fiscal Year 2024
ACELYRIN, Inc.Acelyrin Reports $248.2 Million Net Loss for 2024, Announces Merger with Alumis Inc.
Century Therapeutics, Inc.Century Therapeutics Reports $126.6 Million Net Loss for 2024, Collaboration Revenue Increases
Senti Biosciences Holdings, Inc.Senti Biosciences Reports $52.8 Million Net Loss for 2024, Initiates Phase 1 Clinical Trials
Damora Therapeutics, Inc.Galecto, Inc. Reports $21.4 Million Net Loss for 2024, Highlights Strategic Acquisition and Operational Changes
Amprius Technologies, Inc.Amprius Technologies Reports 167% Revenue Growth to $24.2 Million, Faces Increased Losses
Eledon Pharmaceuticals, Inc.Eledon Pharmaceuticals Reports Improved Financial Performance and Focus on Kidney Transplantation Programs